MRPL35 and gastric cancer: 18 β‐Glycyrrrhetinic acid, a licorice compound, has been proven to inhibit the proliferation of GC cells by targeting the MAPK signaling pathway and regulating cytokines such as MRPL35, COPS5, TP53, thereby playing an anti‐GC role [122, 123].